Actively Recruiting
Nordic Organ Preservation Approach for Nonoperative Management of Rectal Cancer with Complete Clinical Response
Led by Tampere University Hospital · Updated on 2026-09-30
200
Participants Needed
13
Research Sites
208 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying nonoperative management NOM for patients with rectal cancer who achieve a complete clinical response after neoadjuvant therapy. This single-arm, international trial aims to establish a unified NOM protocol and evaluate oncological outcomes, such as organ preservation and local regrowth rates, in Finnish and Estonian treatment settings compared to global experiences. Participants with confirmed complete clinical response will receive nonoperative surveillance including clinical examinations, rectal MRI, endoscopy, and body CT scans. The study involves close monitoring every 3 months during the first 2 years and every 6 months thereafter up to 5 years. No randomization is involved, and treatment aligns with Nordic practice standards. During the trial, participants will undergo regular clinical and imaging assessments to monitor for local regrowth or distant spread. Researchers will measure disease-free survival at 2 years as the primary outcome, alongside secondary outcomes such as overall survival, quality of life, and complication rates up to 5 years. Data will be securely collected and monitored as part of standard care, with safety procedures in place for local recurrence events.
CONDITIONS
Brief Title
Nordic ORgan Preservation Pilot Approach Nonrandomised Single-Arm Trial for Non-Operative Management of Rectal Cancer
Research Team
T
Toni T Seppälä, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here